We are live on ! Find out more
ACIU icon

AC Immune
ACIU

18 hedge funds and large institutions have $117M invested in AC Immune in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

0.04% more ownership

Funds ownership: 19.64% → 19.67% (+0.04%)

18% less funds holding

Funds holding: 22 → 18 (-4)

18% less capital invested

Capital invested by funds: $143M → $117M (-$26.4M)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
18
Holders Change
-4
Holders Change %
-18.18%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
8
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
+$1.22M
2
Renaissance Technologies
Renaissance Technologies
New York
+$831K
3
Deutsche Bank
Deutsche Bank
Germany
+$673K
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$141K
5
VF
Virtu Financial
New York
+$124K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$752K
2
BAM
Belpointe Asset Management
Nevada
-$650K
3
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$206K
4
Wells Fargo
Wells Fargo
California
-$127K
5
Barclays
Barclays
United Kingdom
-$57.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$56.6M +$141K +11,556 +0.2%
DFO
2
Duquesne Family Office
New York
$24.7M – – –
Temasek Holdings
3
Temasek Holdings
Singapore
$13.8M – – –
PC
4
PointState Capital
New York
$10.3M – – –
AG
5
Artal Group
Luxembourg
$6.2M +$1.22M +100,000 +20%
TCM
6
Tekla Capital Management
Massachusetts
$1.78M – – –
Renaissance Technologies
7
Renaissance Technologies
New York
$822K +$831K +68,325 +610%
Morgan Stanley
8
Morgan Stanley
New York
$643K +$46.5K +3,826 +7%
Deutsche Bank
9
Deutsche Bank
Germany
$608K +$673K +55,311 +1,574%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$467K +$13.6K +1,120 +3%
LBC
11
Lawrence B. Cohen
$212K +$91.2K +7,500 +57%
Citadel Advisors
12
Citadel Advisors
Florida
$163K -$752K -61,849 -80%
VF
13
Virtu Financial
New York
$106K +$124K +10,205 New
Barclays
14
Barclays
United Kingdom
$57K -$57.2K -4,700 -46%
Citigroup
15
Citigroup
New York
$51K -$7.3K -600 -11%
CLOS
16
Compagnie Lombard Odier SCmA
Switzerland
$37K -$42.6K -3,500 -50%
UBS Group
17
UBS Group
Switzerland
$22K +$25K +2,057 +3,318%
EDRH
18
Edmond de Rothschild Holding
Switzerland
$16K – – –
BAM
19
Belpointe Asset Management
Nevada
– -$650K -50,750 Closed
Janney Montgomery Scott
20
Janney Montgomery Scott
Pennsylvania
– -$206K -16,066 Closed
Wells Fargo
21
Wells Fargo
California
– -$127K -9,948 Closed
AAMU
22
Amundi Asset Management US
Massachusetts
– -$45K -3,500 Closed
TRCT
23
Tower Research Capital (TRC)
New York
– -$7K -549 Closed

ACIU Hedge Fund Activity: Q1 2018 in Review

18 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q1 2018, worth a combined $117M — down 18% from $143M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ACIU and 1 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 8 added.

The largest buyer was Artal Group, adding an estimated $1.22M. The largest seller was Citadel Advisors, cutting an estimated $752K.

  • 18 institutional investors held AC Immune (ACIU) as of Q1 2018, down from 22 in Q4 2017.
  • Funds reported $117M of AC Immune stock for Q1 2018, down 18% quarter-over-quarter.
  • 1 fund opened new AC Immune positions in Q1 2018 and 5 closed out, a net change of -4 holders.
  • The largest AC Immune buyer in Q1 2018 was Artal Group, an estimated $1.22M added.
  • The largest AC Immune seller in Q1 2018 was Citadel Advisors, an estimated $752K sold.

Based on aggregated 13F filings for Q1 2018.